MedPath

Samsung Bioepis NL B.V.

🇳🇱Netherlands
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

EMA:22
CIMA_AEMPS:20

Drug Approvals

Xbryk

Authorization Status
Authorised
Approval Date
Feb 12, 2025
EMA

Xbryk

Authorization Status
Authorised
Approval Date
Feb 12, 2025
EMA

Obodence

Authorization Status
Authorised
Approval Date
Feb 12, 2025
EMA

Opuviz

Authorization Status
Authorised
Approval Date
Nov 13, 2024
EMA

Opuviz

Authorization Status
Authorised
Approval Date
Nov 13, 2024
EMA

Eksunbi

Authorization Status
Authorised
Approval Date
Sep 12, 2024
EMA

Pyzchiva

Authorization Status
Authorised
Approval Date
Apr 19, 2024
EMA

Pyzchiva

Authorization Status
Authorised
Approval Date
Apr 19, 2024
EMA

Epysqli

Authorization Status
Authorised
Approval Date
May 26, 2023
EMA

Byooviz

Authorization Status
Authorised
Approval Date
Aug 18, 2021
EMA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.